CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Berlin, Germany and 89 other locations
Second-line therapy with Nal-IRI after failure gemcitabine/nab-paclitaxel in advanced pancreatic cancer - predictive role of 1st-li...
Phase 3
Bad Saarow, Germany and 34 other locations
treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in t...
Phase 1, Phase 2
Berlin, Germany and 26 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Berlin, Germany and 91 other locations
PLATON's pilot-study assesses genomic profiling in gastrointestinal cancer therapy and the frequencies of targetable mutations including Tum...
Berlin, Germany and 42 other locations
This is an interventional, open-label, non-randomised, multicentre, single-arm phase II clinical trial.Eligible patients with hepatic oligometastatic...
Phase 2
Berlin, Germany and 10 other locations
given to participants. Part C will use the information from Parts A and B to see if SGN-BB228 is safe and if it works to treat solid tumor cancers...
Phase 1
Berlin, Other, Germany and 17 other locations
efficacy of AZD9574 individually and in combination with anti-cancer agents in 490 participants with advanced cancer that has recur...
Phase 1, Phase 2
Berlin, Germany and 30 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...
Phase 2
Berlin, Germany and 122 other locations
liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...
Phase 3
Berlin, Germany and 199 other locations
Clinical trials
Research sites
Resources
Legal